profit from every $100 of sales.
$0$100
Calumet
$34.30-5.90% today
+87.3% in 1 year
1-year low $18.221-year high $59.05
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Calumet sold, what it kept, and what it did with the cash.
Sales went from $4.69 billion in 2022 to $4.14 billion in 2025, with -$33.8 million of profit last year.
SalesProfit
Calumet vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Calumet | No profit yet | ||
 Linde | 35.0× · Expensive | ||
 L'Air Liquide | 35.1× · Expensive | ||
 Ecolab | 41.8× · Expensive | ||
 The Sherwin-Williams | 32.9× · Expensive |
AI analysis
An AI analyst reads Calumet's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 4,686 | 4,181 | 4,189 | 4,137 | |
| 352 | 452 | 231 | 246 | |
| 133 | 271 | 10 | 54 | |
| 104 | 418 | 165 | 238 | |
| -173 | 48 | -222 | -34 | |
| -2.04 | 0.59 | -2.67 | -0.39 | |
| 7.5% | 10.8% | 5.5% | 5.9% | |
| 2.8% | 6.5% | 0.2% | 1.3% | |
| -3.7% | 1.2% | -5.3% | -0.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2,741 | 2,751 | 2,758 | 2,689 |
| Cash | 35 | 8 | 38 | 125 |
| Total debt | 1,668 | 2,000 | 2,341 | 2,459 |
| Total liabilities | 3,029 | 2,996 | 3,225 | 3,176 |
| 0 | 0 | -712 | -733 | |
| 79 | 80 | 83 | 87 | |
| 0.3% | 10.7% | 0.8% | 4.1% | |
| – | – | 31.2% | 4.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 101 | -15 | -46 | 109 | |
| 536 | 272 | 77 | 52 | |
| -436 | -287 | -123 | 57 | |
| Dividends paid | – | – | – | – |
| 4 | 0 | 0 | – | |
| 17 | 15 | 15 | -5 |
Valuation
- –
- 448.4×
- –
- -4.4×
- 0.7×
- 53.4×
- 22.5×
- 1.9%
- -1.1%
- 0.0%
Profitability
- 5.9%
- 1.3%
- -0.8%
- 2.6%
- 4.2%
- 4.1%
- 21.7%
- -6.9%
- -0.7%
- –
Growth
- −4.1%
- –
- +146.0%
- –
- +3.0%
Financial health
- 9.8×
- -3.36
- 1.2%
- 0.4×
- 1.02
- 0.58
- 1.51
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 35%of 990
Bottom 13%of 950
Bottom 24%of 929
Bottom 46%of 987
What analysts expect
- Average price target
- $31.00
- Range
- $26.00 – $36.00
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 8, 2026 | -0.64 | -0.57 | −12.3% |
| Feb 27, 2026 | -0.43 | -0.67 | +35.8% |
| Nov 7, 2025 | -0.21 | -0.30 | +30.0% |
| Aug 8, 2025 | -1.70 | -0.44 | −286.4% |
| May 9, 2025 | -1.03 | -0.41 | −151.2% |
| Feb 28, 2025 | -0.47 | -1.06 | +55.7% |
| Nov 8, 2024 | -0.81 | -0.59 | −37.3% |
| Aug 9, 2024 | -0.48 | -0.70 | +31.4% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
3No pass
Benjamin Graham
9No pass
Philip Fisher
20No pass
Peter Lynch
7No pass
Joel Greenblatt
0No pass
Charlie Munger
14No pass
Terry Smith
10No pass
Questions about Calumet
Is Calumet a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Calumet AI analysis
What does Calumet do?
Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. It is in Specialty Chemicals, based in Indianapolis, IN, United States, with 1,540 employees.
Does Calumet pay a dividend?
No. Calumet does not pay a dividend at the moment.
Is Calumet stock halal?
No. Calumet does not pass our halal screen: its debt is 81% of its market value, at or above the 33% limit. How we check
How has Calumet stock done over the past year?
Up 87.3% over the past twelve months, to $34.30. It traded between $18.22 and $59.05 and is 41.9% below its high.
Who are Calumet's competitors?
The largest listed companies in the same industry are Linde, L'Air Liquide, Ecolab and The Sherwin-Williams. The peers table on this page compares their profit, growth and price with Calumet's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.